Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Cambridge Cognition Holdings's EV-to-EBIT or its related term are showing as below:
LSE:COG'
s EV-to-EBIT Range Over the Past 10 Years
Min: -115.55 Med: -9.74 Max: 257.68
Current: -13.79
During the past 13 years, the highest EV-to-EBIT of Cambridge Cognition Holdings was 257.68. The lowest was -115.55. And the median was -9.74.
LSE:COG's EV-to-EBIT is ranked worse than 100% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 15.87
vs LSE:COG: -13.79
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Cambridge Cognition Holdings's Enterprise Value for the quarter that ended in Dec. 2025 was £12.78 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cambridge Cognition Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was £-1.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Cognition Holdings EV-to-EBIT Related Terms
Cambridge Cognition Holdings EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Cambridge Cognition Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cambridge Cognition Holdings EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cambridge Cognition Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Cambridge Cognition Holdings's EV-to-EBIT falls into.
Cambridge Cognition Holdings's current Enterprise Value is £17.28 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cambridge Cognition Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was £-1.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Cognition Holdings (LSE:COG) has a EV-to-EBIT of -13.79 as of Jul. 28, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cambridge Cognition Holdings and its competitors. According to the industry distribution chart, Cambridge Cognition Holdings ranks #999999 out of 471 companies in the Healthcare Providers & Services industry.
Is Cambridge Cognition Holdings' EV-to-EBIT too high?
Cambridge Cognition Holdings' current EV-to-EBIT is -13.79. Based on the distribution chart, Cambridge Cognition Holdings ranks #999999 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cambridge Cognition Holdings has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cambridge Cognition Holdings' EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Cambridge Cognition Holdings ranks #999999 out of 471 companies for EV-to-EBIT. This places Cambridge Cognition Holdings in the lower half of its industry. The industry median EV-to-EBIT is 15.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cambridge Cognition Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cambridge Cognition Holdings's current EV-to-EBIT is -13.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Cognition Holdings stock overvalued right now?
Based on GuruFocus' analysis, Cambridge Cognition Holdings (LSE:COG) is currently considered Fairly Valued. The stock's GF Value™ is £0.33, compared to a current price of £0.33 — trading 1.5% below its estimated fair value. The current EV-to-EBIT is -13.79. Cambridge Cognition Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Cambridge Cognition Holdings (LSE:COG), the current EV-to-EBIT is -13.79 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cambridge Cognition Holdings (LSE:COG) Overvalued in 2026?
Based on GuruFocus' analysis, Cambridge Cognition Holdings stock appears to be undervalued.
The current stock price of £0.33 is trading 1.5% below its estimated GF Value™ of £0.33.
GuruFocus considers Cambridge Cognition Holdings to be Fairly Valued.
Key valuation signals for LSE:COG:
EV-to-EBIT: -13.79
GF Value™: £0.33 vs. price of £0.33 (1.5% below fair value)
No single metric tells the full story. See the LSE:COG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the measurement of clinical outcomes in neurological disorders. It develops and commercialises neuroscience technologies to assess cognitive function for sale across the world. The company's products include CANTAB web-based assessments, Electronic questionnaires and scales (eCOA), NeuroVocalix Winterlight, a voice analysis tool to assess cognitive changes, high-frequency testing kits, and Clinpal, among others. Its operating segments are: Clinical studies, which generate maximum revenue, Academic research, Professional Healthcare, and Consumer Health & Wellness. Geographically, the company generates maximum revenue from the USA, and the rest from the UK, the European Union, and the Rest of the world.
47GF Score
Get the complete analysis for LSE:COG
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:COG has been successfully added to your 
